Bellerophon Therapeutics在盘前股价暴跌39%,因公司将被纳斯达克摘牌。查看全文
临床治疗药物公司Bellerophon(BLPH.O)盘初跳涨18%,触及熔断。 网页链接
$柏勒罗丰治疗(BLPH)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001600132-20-000087 Size: 3 KB 网页链接
$柏勒罗丰治疗(BLPH)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001600132-20-000085 Act: 34 Size: 220 KB 网页链接
$柏勒罗丰治疗(BLPH)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001600132-20-000084 Act: 34 Size: 4 MB 网页链接
$柏勒罗丰治疗(BLPH)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001104659-20-084551 Act: 33 Size: 355 KB 网页链接
$柏勒罗丰治疗(BLPH)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001104659-20-084552 Act: 34 Size: 271 KB 网页链接
$柏勒罗丰治疗(BLPH)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001600132-20-000078 Act: 34 Size: 70 KB 网页链接
$柏勒罗丰治疗(BLPH)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-20-001640 Act: 33 Size: 1 KB 网页链接
$柏勒罗丰治疗(BLPH)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001600132-20-000070 Act: 33 Size: 1 MB 网页链接
$柏勒罗丰治疗(BLPH)$ 8-K Current report, item 5.07 Accession Number: 0001600132-20-000067 Act: 34 Size: 38 KB 网页链接
$柏勒罗丰治疗(BLPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001600132-20-000062 Size: 5 KB 网页链接